Bio-Techne Corp (TECH)
76.18
+2.75
(+3.75%)
USD |
NASDAQ |
May 02, 14:59
Bio-Techne Cash from Operations (Quarterly): 83.12M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 83.12M |
| September 30, 2023 | 59.38M |
| June 30, 2023 | 83.39M |
| March 31, 2023 | 50.54M |
| December 31, 2022 | 64.38M |
| September 30, 2022 | 56.08M |
| June 30, 2022 | 102.72M |
| March 31, 2022 | 73.13M |
| December 31, 2021 | 100.99M |
| September 30, 2021 | 48.43M |
| June 30, 2021 | 122.02M |
| March 31, 2021 | 74.87M |
| December 31, 2020 | 89.27M |
| September 30, 2020 | 66.01M |
| June 30, 2020 | 44.79M |
| March 31, 2020 | 49.47M |
| December 31, 2019 | 70.42M |
| September 30, 2019 | 40.54M |
| June 30, 2019 | 55.95M |
| March 31, 2019 | 39.66M |
| December 31, 2018 | 46.56M |
| September 30, 2018 | 39.45M |
| June 30, 2018 | 64.84M |
| March 31, 2018 | 21.65M |
| December 31, 2017 | 39.18M |
| Date | Value |
|---|---|
| September 30, 2017 | 44.70M |
| June 30, 2017 | 50.85M |
| March 31, 2017 | 25.02M |
| December 31, 2016 | 41.63M |
| September 30, 2016 | 26.22M |
| June 30, 2016 | 36.65M |
| March 31, 2016 | 37.14M |
| December 31, 2015 | 38.54M |
| September 30, 2015 | 31.83M |
| June 30, 2015 | 37.14M |
| March 31, 2015 | 30.78M |
| December 31, 2014 | 35.73M |
| September 30, 2014 | 35.72M |
| June 30, 2014 | 37.92M |
| March 31, 2014 | 34.93M |
| December 31, 2013 | 31.32M |
| September 30, 2013 | 32.58M |
| June 30, 2013 | 29.99M |
| March 31, 2013 | 33.02M |
| December 31, 2012 | 31.29M |
| September 30, 2012 | 29.26M |
| June 30, 2012 | 37.41M |
| March 31, 2012 | 34.46M |
| December 31, 2011 | 20.44M |
| September 30, 2011 | 34.43M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
40.54M
Minimum
Sep 2019
122.02M
Maximum
Jun 2021
70.29M
Average
66.01M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| Agilent Technologies Inc | 485.00M |
| Bio-Rad Laboratories Inc | 81.05M |
| Revvity Inc | 147.56M |
| Twist Bioscience Corp | -22.97M |
| AIM ImmunoTech Inc | -9.758M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -23.67M |
| Cash from Financing (Quarterly) | -81.40M |
| Free Cash Flow | 225.39M |
| Free Cash Flow Per Share (Quarterly) | 0.4264 |
| Free Cash Flow to Equity (Quarterly) | 61.25M |
| Free Cash Flow to Firm (Quarterly) | 71.14M |
| Free Cash Flow Yield | 1.83% |